Rye Brook Capital’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-38,700
Closed -$1.51M 33
2020
Q4
$1.51M Buy
+38,700
New +$1.37M 1.32% 18

Other funds holding KURE

Rye Brook Capital's KURE Position: Q1 2021 in Review

Rye Brook Capital sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q1 2021, closing a stake of 38,700 shares — an estimated $1.51M sold.

Rye Brook Capital first reported a position in KURE in Q4 2020 and held it in 1 quarter. The position peaked at $1.51M in Q4 2020. 27 funds tracked by Wall St. Rank hold KURE as of Q1 2021.

  • Rye Brook Capital reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q1 2021 after selling out during the quarter.
  • Rye Brook Capital sold 38,700 KraneShares MSCI All China Health Care Index ETF shares in Q1 2021, an estimated $1.51M.
  • Rye Brook Capital first reported a position in KraneShares MSCI All China Health Care Index ETF in Q4 2020 and held it in 1 quarter.
  • Rye Brook Capital's KraneShares MSCI All China Health Care Index ETF position peaked at $1.51M in Q4 2020.
  • 27 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2021.

Based on Rye Brook Capital's 13F filing for Q1 2021, filed 9 Apr 2021.